Bill

Bill > S1260


NJ S1260

Requires health insurers to provide coverage for treatment of tick-borne diseases.


summary

Introduced
02/03/2022
In Committee
02/03/2022
Crossed Over
Passed
Dead
01/08/2024

Introduced Session

2022-2023 Regular Session

Bill Summary

This bill requires health insurers (health, hospital and medical service corporations, commercial individual and group health insurers, health maintenance organizations, health benefits plans issued pursuant to the New Jersey Individual Health Coverage and Small Employer Health Benefits Programs, the State Health Benefits Program, and the School Employees' Health Benefits Program) to provide coverage for expenses incurred in the treatment of a tick-borne disease. Treatment otherwise eligible for benefits pursuant to this bill may not be denied solely because such treatment may be characterized as experimental or investigational in nature or because the treatment requires the use of a prescription drug in an off-label manner.

AI Summary

This bill requires health insurers (including hospital service corporations, medical service corporations, health service corporations, individual and group health insurers, health maintenance organizations, and state and school employee health benefits programs) to provide coverage for expenses incurred in the treatment of tick-borne diseases, including long-term antibiotic therapy and ongoing testing. The bill also prohibits insurers from denying coverage for treatments that may be considered experimental or involve off-label use of prescription drugs, as long as the treatments meet certain medical standards.

Committee Categories

Business and Industry

Sponsors (1)

Last Action

Introduced in the Senate, Referred to Senate Commerce Committee (on 02/03/2022)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...